LI:EURONEXT PARISKlepierre SA Analysis
Data as of 2026-03-11 - not real-time
$17.76
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Li Auto trades at $17.76, comfortably above its 20‑day SMA (18.06) and 50‑day SMA (17.41) but well below the 200‑day SMA (22.32), indicating short‑term resilience amid a longer‑term downtrend. The RSI sits near 51, suggesting neutral momentum, while the MACD histogram is negative and the MACD line sits below the signal line, flagging bearish technical pressure. Volume is increasing, and the price is perched just above the identified support at $16.62, with resistance near $19.32. Fundamentally, the stock appears cheap with a PE of 16.1, a price‑to‑sales of 0.14 and an upside potential of roughly 33% based on analyst targets, yet revenue has contracted 36% year‑over‑year and operating cash flow is negative. Gross margins are modest at 19.4% and operating margins are in the red (-4.3%), though the company holds a strong cash balance of $98.7 bn against $17.9 bn of debt. Recent analyst actions have been negative – JPMorgan cut its rating to Underweight with a $14 price objective and Macquarie downgraded to Underperform with a $15 target – reflecting concerns over profitability and cash‑flow sustainability. Delivery volumes remain solid, with 27,668 vehicles shipped in January 2026, pushing cumulative deliveries past 1.56 million, which underpins the longer‑term growth narrative.
Given the high 30‑day volatility (≈37%) and a beta below 1, the stock is less correlated with broader market moves but still subject to significant price swings. The combination of a strong cash cushion, attractive valuation multiples, and a sizable upside target supports a longer‑term bullish case, while the current technical bearishness, analyst downgrades, and negative cash flow argue for caution in the near term.
Given the high 30‑day volatility (≈37%) and a beta below 1, the stock is less correlated with broader market moves but still subject to significant price swings. The combination of a strong cash cushion, attractive valuation multiples, and a sizable upside target supports a longer‑term bullish case, while the current technical bearishness, analyst downgrades, and negative cash flow argue for caution in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and recent analyst downgrades
- Price near technical support at $16.62
- Increasing volume but limited upside in the next weeks
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Undervalued valuation multiples (PE 16x, P/S 0.14x)
- Strong cash position versus debt
- Continued delivery growth supporting revenue recovery
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term EV market expansion in China
- Substantial upside potential (~33% to analyst target)
- Strategic brand positioning and product pipeline
Key Metrics & Analysis
Financial Health
Revenue Growth-36.20%
Profit Margin3.63%
P/E Ratio16.1
ROE6.64%
ROA1.49%
Debt/Equity24.44
P/B Ratio1.7
Op. Cash Flow$-3452465920
Free Cash Flow$-11024158720
Technical Analysis
TrendNeutral
RSI50.7
Support$16.62
Resistance$19.32
MA 20$18.06
MA 50$17.41
MA 200$22.32
MACDBearish
VolumeIncreasing
Fear & Greed Index76.5
Valuation
Target Price$23.61
Upside/Downside32.94%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.71
Volatility37.02%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.